Indeed, primary blast crisis CML cells showed 1.45-fold higher levels of ATF4 than chronic phase CML cells in a flow cytometry assay, used instead of Western blotting due to limited number of cells (Figure 4D). The gene discussed is ATF4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.